Skip to main content

Prime Medicine, Inc 10-Q for FY2023 Q2

Prime Medicine, Inc. (PRME)

10-Q 2023-08-07 For: 2023-06-30
View Original
Added on April 07, 2026

About this 10-Q

Prime Medicine, Inc filed this 10-Q on August 7, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).

Headline figures

Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$42.39M
compared with a net loss of $29.35M a year earlier
Diluted EPS
-$0.47
compared with -$1.76 a year earlier